top of page
Starting August 1, 2024, Quickarrays Inc. will be taking over Pantomics Inc. to
provide all products and services. Please visit Quickarrays Inc. for more information.
SERVICES
CUSTOM TMA
ROUTINE PATHOLOGY
IHC / IMMUNOFLUORESCENCE
ISH / FISH
CONTRACTED SERVICES
PRIMARY IHC ANTIBODIES
PATHOLOGY FIELD
DETECTION SYSTEMS
ANCILLARIES
CONTROL TMA
Hermatopathology
NPC962
Nasopharyngeal carcinoma tissue array, set 2, non-overlapping with NPC111, NPC481, NPC961, NPC1501, NPC1502 or NPC1503, containing 88 cases of primary tumors, 8 cases of lymph node metastatic tumors.
Specification
Data Sheet
TNM Grading
Downloads
Price
Size
Availability
Inquire
1 slide
In-Stock
A | |
B | |
C | |
D | |
E | |
F | |
G | |
H | |
TNM Classification : Nasopharygeal carcinoma
T - Primary Tumor
TX - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ
T1 - Tumor confined to nasopharynx
T2 - Tumor estends to soft tissue of oropharynx and/or nasal fossa
T2a – without parapharyngeal extension
T2b – with parapharyngeal extension
T3 - Tumor invades bony structures and/or paranasal sinuses
T4 - Tumor with intracranial extension and/or involvement of cranial nerves, infratemporal fossa, hypopharynx, or orbit
N - Regional Lymph nodes
NX - Reginal lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Unilateral metastasis in lymph node(s), 6cm or less in greatest dimension, above supraclavicular fossa
N2 - Bilateral metastasis in lymph node(s), 6cm or less in greatest dimension, above supraclavicular fossa
N3 - Metastasis in lymph node(s)
(a) greater than 6cm in dimension
(b) in the supraclavicular
M - Distant Metastasis
MX - Distant metastasis cannot be assessed
M0 - No distant metasissis
M1 - Distant metastasis
Human
96
96
1.5mm
4um
8
12
Paraffin
Notes:
All tissues were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or Startfrost Adhesive slides. They all have a guaranteed six month shelf-life at 4C from the date of shipment. Additional cores not listed are orientation markers and have no data. There maybe <5% core loss per slide but the core retention rate should be >90%.
Bake at 60C for 30 minutes before use. If antigen retrieving is needed, it is always a good idea to start with a protocol with weak to mild strength. Please check our TNM guide as a reference. For IHC related information on products that provide them, please contact us at info@pantomics.com for the most up-to-date information.
For research use only. Designed for comparative IHC or ISH based protein or RNA tissue profiling in paired primary and metastatic tumor tissues from multiple nasopharyngeal carcinoma patients.
ARRAY POSITION | IMAGE | SEX | AGE | ANATOMIC SITE | PATHOLOGY | GRADE | STAGE (TNM) |
|---|---|---|---|---|---|---|---|
A01 | M | 48 | Head and neck, nasopharynx | Squamous cell carcinoma | III | ||
A02 | M | 45 | Head and neck, nasopharynx | Squamous cell carcinoma | III | ||
A03 | M | 29 | Head and neck, nasopharynx | Squamous cell carcinoma | III | ||
A04 | F | 40 | Head and neck, nasopharynx | Squamous cell carcinoma | III | ||
A05 | F | 40 | Head and neck, nasopharynx | Squamous cell carcinoma | III | ||
A06 | M | 45 | Head and neck, nasopharynx | Squamous cell carcinoma | III | ||
A07 | M | 45 | Head and neck, nasopharynx | Squamous cell carcinoma | III | ||
A08 | M | 41 | Head and neck, nasopharynx | Squamous cell carcinoma | III | ||
A09 | M | 35 | Head and neck, nasopharynx | Squamous cell carcinoma | III | ||
A10 | M | 61 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T2N1M0 | |
A11 | M | 40 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T2N1M1 | |
A12 | F | 46 | Head and neck, nasopharynx | Squamous cell carcinoma | III | ||
B01 | M | 48 | Lymph node | Metastatic nasopharygeal carcinoma, NPC | |||
B02 | M | 45 | Lymph node | Metastatic nasopharygeal carcinoma, NPC | |||
B03 | M | 29 | Lymph node | Metastatic nasopharygeal carcinoma, NPC | |||
B04 | F | 40 | Lymph node | Metastatic nasopharygeal carcinoma, NPC | |||
B05 | F | 40 | Lymph node | Metastatic nasopharygeal carcinoma, NPC | |||
B06 | M | 45 | Lymph node | Metastatic nasopharygeal carcinoma, NPC | |||
B07 | M | 45 | Lymph node | Metastatic nasopharygeal carcinoma, NPC | |||
B08 | M | 41 | Lymph node | Metastatic nasopharygeal carcinoma, NPC | |||
B09 | M | 35 | Head and neck, nasopharynx | Squamous cell carcinoma | |||
B10 | M | 61 | Head and neck, nasopharynx | Squamous cell carcinoma | |||
B11 | M | 40 | Head and neck, nasopharynx | Squamous cell carcinoma | |||
B12 | F | 46 | Head and neck, nasopharynx | Squamous cell carcinoma | |||
C01 | M | 42 | Head and neck, nasopharynx | Squamous cell carcinoma | III | ||
C02 | M | 48 | Head and neck, nasopharynx | Squamous cell carcinoma | III | ||
C03 | M | 42 | Head and neck, nasopharynx | Squamous cell carcinoma | III | ||
C04 | M | 37 | Head and neck, nasopharynx | Squamous cell carcinoma | III | ||
C05 | F | 47 | Head and neck, nasopharynx | Squamous cell carcinoma | III | ||
C06 | M | 44 | Head and neck, nasopharynx | Squamous cell carcinoma | III | ||
C07 | M | 50 | Head and neck, nasopharynx | Squamous cell carcinoma | III | ||
C08 | M | 40 | Head and neck, nasopharynx | Squamous cell carcinoma | III | ||
C09 | M | 56 | Head and neck, nasopharynx | Squamous cell carcinoma | III | ||
C10 | F | 48 | Head and neck, nasopharynx | Squamous cell carcinoma | III | ||
C11 | M | 24 | Head and neck, nasopharynx | Squamous cell carcinoma | III | ||
C12 | M | 35 | Head and neck, nasopharynx | Squamous cell carcinoma | III | ||
D01 | M | 42 | Head and neck, nasopharynx | Squamous cell carcinoma | III | ||
D02 | M | 48 | Head and neck, nasopharynx | Squamous cell carcinoma | III | ||
D03 | M | 42 | Head and neck, nasopharynx | Squamous cell carcinoma | III | ||
D04 | M | 37 | Head and neck, nasopharynx | Squamous cell carcinoma | III | ||
D05 | F | 47 | Head and neck, nasopharynx | Squamous cell carcinoma | III | ||
D06 | M | 44 | Head and neck, nasopharynx | Squamous cell carcinoma | III | ||
D07 | M | 50 | Head and neck, nasopharynx | Squamous cell carcinoma | III | ||
D08 | M | 40 | Head and neck, nasopharynx | Squamous cell carcinoma | III | ||
D09 | M | 56 | Head and neck, nasopharynx | Squamous cell carcinoma | III | ||
D10 | F | 48 | Head and neck, nasopharynx | Squamous cell carcinoma | III | ||
D11 | M | 24 | Head and neck, nasopharynx | Squamous cell carcinoma | III | ||
D12 | M | 35 | Head and neck, nasopharynx | Squamous cell carcinoma | III | ||
E01 | M | 33 | Head and neck, nasopharynx | Vesicular nucleus cell carcinoma | T3N0M0 | ||
E02 | M | 28 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T1N0M0 | |
E03 | F | 0 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T2N1M0 | |
E04 | M | 47 | Head and neck, nasopharynx | Vesicular nucleus cell carcinoma | III | T1N0M0 | |
E05 | M | 36 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T3N0M0 | |
E06 | F | 48 | Head and neck, nasopharynx | Vesicular nucleus cell carcinoma | III | T2N1M0 | |
E07 | M | 35 | Head and neck, nasopharynx | Squamous cell carcinoma | III | ||
E08 | M | 43 | Head and neck, nasopharynx | Vesicular nucleus cell carcinoma | III | T3N0M0 | |
E09 | F | 45 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T4N0M0 | |
E10 | M | 40 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T3N2M0 | |
E11 | M | 70 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T2N3M0 | |
E12 | M | 33 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T2N0M0 | |
F01 | M | 83 | Head and neck, nasopharynx | Vesicular nucleus cell carcinoma | T2N2M0 | ||
F02 | F | 48 | Head and neck, nasopharynx | Squamous cell carcinoma | II | T2N2M0 | |
F03 | M | 56 | Head and neck, nasopharynx | Squamous cell carcinoma | III | ||
F04 | M | 33 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T4N1M0 | |
F05 | M | 56 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T3N1M0 | |
F06 | M | 44 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T1N1M0 | |
F07 | M | 51 | Head and neck, nasopharynx | Vesicular nucleus cell carcinoma | T2N1M0 | ||
F08 | M | 37 | Head and neck, nasopharynx | Vesicular nucleus cell carcinoma | T3N0M0 | ||
F09 | M | 48 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T2N1M0 | |
F10 | M | 75 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T3N1M0 | |
F11 | M | 41 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T4N1M0 | |
F12 | M | 48 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T3N2M0 | |
G01 | M | 47 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T1N1M0 | |
G02 | M | 53 | Head and neck, nasopharynx | Vesicular nucleus cell carcinoma | T3N1M0 | ||
G03 | M | 27 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T2N1M0 | |
G04 | M | 52 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T2N1M0 | |
G05 | M | 40 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T2N1M0 | |
G06 | M | 13 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T3N2M1 | |
G07 | M | 63 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T1N1M0 | |
G08 | F | 60 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T3N3M0 | |
G09 | M | 63 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T4N3M0 | |
G10 | F | 43 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T2N3M0 | |
G11 | F | 50 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T3N1M0 | |
G12 | F | 53 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T1N1M0 | |
H01 | F | 60 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T2N2M0 | |
H02 | F | 40 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T2N2M1 | |
H03 | F | 34 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T2N2M0 | |
H04 | M | 42 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T4N1M1 | |
H05 | M | 56 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T2N3M0 | |
H06 | M | 42 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T3N1M0 | |
H07 | M | 52 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T3N1M0 | |
H08 | M | 45 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T2N3M0 | |
H09 | M | 48 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T2N0M0 | |
H10 | F | 49 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T2N1M0 | |
H11 | M | 55 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T2N1M1 | |
H12 | F | 66 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T4N1M0 | |
null |
bottom of page